Who owns the ARRIVENT trademark?

The ARRIVENT trademark is owned by ArriVent BioPharma, Inc..

What is the serial number for ARRIVENT?

The USPTO serial number for ARRIVENT is 98228980.

What is the registration number for ARRIVENT?

ARRIVENT is registered under USPTO registration number 7877640.

ARR

USPTO Trademark Record

REGISTERED

ARRIVENT

Q: What class is the ARRIVENT trademark registered in?

The ARRIVENT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 98228980·Reg 7877640·Filed Oct 18, 2023

Owner ArriVent BioPharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ARRIVENT (Serial No. 98228980), Registration No. 7877640, is a registered US trademark filed on Oct 18, 2023 by ArriVent BioPharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: August 05, 2031

Mark Intelligence

ARRIVENT (Reg. #7877640) is a registered US trademark that has been protecting its owner, ArriVent BioPharma, Inc., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 18, 2023

SERIAL

98228980

REG#

7877640

REGISTERED

Aug 05, 2025

Owner

Applicant

ArriVent BioPharma, Inc.

Entity

Corporation

State

Address

18 Campus Blvd., Suite 100, Newtown Square, PA, 190733269

Country

Attorney

NameWade Savoy

Law firm

Wade Savoy PATENT GC LLC

Docket

ARRIVENT

Address

501 BOYLSTON STREET, 10TH FLOOR, BOSTON, MA 02116, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 18, 2023

Serial Number98228980

Registration No.7877640

Registration DateAug 05, 2025

Status DateAug 05, 2025

Published for OppositionDec 31, 2024

Mark TypeStandard characters

Attorney DocketARRIVENT

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 14, 2024

First use in commerce: Nov 14, 2024

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 26, 2021

First use in commerce: Oct 26, 2021

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

REGISTERED-PRINCIPAL REGISTER

Aug 05, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 05, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Jul 10, 2025

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

EXTENSION OF TIME TO OPPOSE RECEIVED

Jan 30, 2025

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Dec 31, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 31, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 25, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

USE AMENDMENT ACCEPTED

Dec 05, 2024

USE AMENDMENT ACCEPTED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 05, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 04, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 04, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 04, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS AMENDMENT OF USE RECEIVED

Dec 04, 2024

TEAS AMENDMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 04, 2024

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Dec 04, 2024

AMENDMENT TO USE PROCESSING COMPLETE

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jul 15, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jul 15, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Jun 10, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 10, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 10, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jun 04, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 24, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 21, 2023

NEW APPLICATION ENTERED

ARRIVENT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by ArriVent BioPharma, Inc.

Other Marks by Wade Savoy

Industries

USPTO Deadlines

Compare

Resources

Company